MDM SpA Dear visitor, thank you for visiting the site. from 1 May 2020 MDM merged into Neopharmed Gentili SpA ., a pharmaceutical company specializing in the marketing of solutions with high therapeutic value. To report a potential adverse event that occurs with the use of an MDM drug, you can: - fill in the appropriate reporting form following the instructions given at the following link: www.aifa.gov.it/moduli-segnalazione-reazioni-avverse - follow the guided procedure on the Vigifarmaco website www.vigifarmaco.it - contact your doctor or pharmacist who will forward the report to the reference structure. Alternatively, you can make a report directly to the Company at the addresses listed below. phv@neogen.it For any further information, visit the website www.neogen.it Thank you, see you soon © MDM SpA 2020